Literature DB >> 30140846

Trends in Mammography Use Among Women Aged 40 to 49 Years With a History of Breast Cancer.

Jessica M Bensenhaver1, Angy P Perez Martinez2, Peter G Albert3, Sarah T Hawley4,5, Lindsay F Petersen1, Lisa A Newman1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30140846      PMCID： PMC6583012          DOI： 10.1001/jamasurg.2018.2690

Source DB:  PubMed          Journal:  JAMA Surg        ISSN： 2168-6254            Impact factor:   14.766


× No keyword cloud information.
  5 in total

1.  The public's response to the U.S. Preventive Services Task Force's 2009 recommendations on mammography screening.

Authors:  Linda B Squiers; Debra J Holden; Suzanne E Dolina; Annice E Kim; Carla M Bann; Jeanette M Renaud
Journal:  Am J Prev Med       Date:  2011-05       Impact factor: 5.043

2.  Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.

Authors:  Hazel B Nichols; Amy Berrington de González; James V Lacey; Philip S Rosenberg; William F Anderson
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

3.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

Review 4.  American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.

Authors:  Carolyn D Runowicz; Corinne R Leach; N Lynn Henry; Karen S Henry; Heather T Mackey; Rebecca L Cowens-Alvarado; Rachel S Cannady; Mandi L Pratt-Chapman; Stephen B Edge; Linda A Jacobs; Arti Hurria; Lawrence B Marks; Samuel J LaMonte; Ellen Warner; Gary H Lyman; Patricia A Ganz
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

5.  Awareness of the 2009 US Preventive Services Task Force recommended changes in mammography screening guidelines, accuracy of awareness, sources of knowledge about recommendations, and attitudes about updated screening guidelines in women ages 40-49 and 50+.

Authors:  Marc T Kiviniemi; Jennifer L Hay
Journal:  BMC Public Health       Date:  2012-10-24       Impact factor: 3.295
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.